Articles dans des revues avec comité de lecture (84)
  1. 1. Francisse, S., Gkolfakis, P., Fernandez Y Viesca, M., Mans, L., Demols, A., Pezzullo, M., Loi, P., Navez, J., Closset, J., Bali, M. A., Van Wettere, M., D'Haene, N., Demetter, P., Verset, L., Bouchart, C., Lemmers, A., Devière, J., Delhaye, M., Van Laethem, J.-L., & Arvanitakis, M. (2023). The impact of a multidisciplinary team approach on the management of focal pancreatic lesions: a single tertiary center experience. Annals of Gastroenterology, 36(5), 580-587. doi:10.20524/aog.2023.0827
  2. 2. Moeremans, M., Avni, F., D'Haene, N., Lam, N. M., Metens, T., & D'Hondt, A. (2023). Combined prenatal US and post-mortem fetal MRI: can they replace conventional autopsy for fetal body abnormalities? European radiology. doi:10.1007/s00330-023-09847-y
  3. 3. Demols, A., Rocq, L., Perez-Casanova Garcia, L., Charry, M., De Nève, N., Ramadhan, A. M., Van Campenhout, C., De Clercq, S., Maris, C., Closset, J., Lucidi, V., Salmon, I., & D'Haene, N. (2023). A Two-Step Diagnostic Approach for NTRK Gene Fusion Detection in Biliary Tract and Pancreatic Adenocarcinomas. The oncologist, 28(7), e520-e525. doi:10.1093/oncolo/oyad075
  4. 4. Racu, M.-L., Bernardi, D., Chaouche, A., Zindy, E., Navez, J., Loi, P., Maris, C., Closset, J., Van Laethem, J.-L., Decaestecker, C., Salmon, I., & D'Haene, N. (2023). SMAD4 Positive Pancreatic Ductal Adenocarcinomas Are Associated with Better Outcomes in Patients Receiving FOLFIRINOX-Based Neoadjuvant Therapy. Cancers (Basel), 15(15). doi:10.3390/cancers15153765
  5. 5. Lebrun, L., Absil, L., Remmelink, M., De Mendonça, R., D'Haene, N., Gaspard, N., Rusu, S., Racu, M.-L., Collin, A., Allard, J., Zindy, E., Schiavo, A. A., De Clercq, S., De Witte, O., Decaestecker, C., Lopes, M. B., & Salmon, I. (2023). SARS-Cov-2 infection and neuropathological findings: a report of 18 cases and review of the literature. Acta neuropathologica communications, 11(78). doi:10.1186/s40478-023-01566-1
  6. 6. Crake, R., Gasmi, I., Dehaye, J., Lardinois, F., Peiffer, R., Maloujahmoum, N., Agirman, F., Koopmansch, B., D'Haene, N., Azurmendi Senar, O., Arsenijevic, T., Lambert, F., Peulen, O., Van Laethem, J.-L., & Bellahcène, A. (2023). Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response. Cells, 12(10), 1414. doi:10.3390/cells12101414
  7. 7. Derasse, M., D'Haene, N., Berghmans, T., & Grigoriu, B. D. (2022). Liquid Biopsy for Detection of T790M Mutation in Patient with EGFR-Mutant Non-Small Cell Lung Cancer with Leptomeningeal Metastases: A Case Report. Annals of clinical research, 7, 2361.
  8. 8. Dufraing, K., Van Casteren, K., Breyne, J., D'Haene, N., Van Campenhout, C., Vander Borght, S., Zwaenepoel, K., Rouleau, E., Schuuring, E., von der Thüsen, J., & Dequeker, E. (2022). Molecular pathology testing for non-small cell lung cancer: an observational study of elements currently present in request forms and result reports and the opinion of different stakeholders. BMC cancer, 22(1), 736. doi:10.1186/s12885-022-09798-5
  9. 9. Pasau, T., Wauters, E., Wauters, I., Duplaquet, F., Pirard, L., Stanciu-Pop, C., D'Haene, N., Dupont, M., Vander Borght, T., Rondelet, B., & Ocak, S. (2022). Case report: BRAF A598-T599insV mutation as a potential resistance mechanism to alectinib in ALK-rearranged lung adenocarcinoma. Frontiers in oncology, 12, 985446. doi:10.3389/fonc.2022.985446
  10. 10. Racu, M.-L., Lebrun, L., Schiavo, A. A., Van Campenhout, C., De Clercq, S., Absil, L., Minguijon Perez, E., Maris, C., Decaestecker, C., Salmon, I., & D'Haene, N. (2022). The Role of SMAD4 Inactivation in Epithelial-Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link? Cancers (Basel), 14(4). doi:10.3390/cancers14040973
  11. 11. Verocq, C., Racu, M.-L., Bafort, D., Butorano, G., Perez-Casanova Garcia, L., Navez, J., Witterwulghe, M., Sheahan, K., Swan, N., Closset, J., Van Laethem, J.-L., Maris, C., & D'Haene, N. (2021). Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report. Diagnostic Pathology, 16(1). doi:10.1186/s13000-021-01178-0
  12. 12. Rusu, S., Verocq, C., Trepant, A.-L., Maris, C., De Nève, N., Blanchard, O., Van Campenhout, C., De Clercq, S., Rorive, S., Cotoi, O. S., Decaestecker, C., Salmon, I., & D'Haene, N. (2021). Immunohistochemistry as an accurate tool for the assessment of BRAF V600E and TP53 mutations in primary and metastatic melanoma. Molecular and clinical oncology, 15(6), 270. doi:10.3892/mco.2021.2432
    13. << Précédent 1 2 3 4 5 6 7 8 9 Suivant >>